Hong Wei Ouyang (Sports medicine & Stem Cells and Regenerative Medicine)
Director for School of Basic Medical Science, Zhejiang University
Professor Ouyang focuses on the research of tissue engineering and regenerative therapy of tendon and cartilage. With the development of a functional silk scaffolds as well as the stepwise differentiation of embryonic or adult stem cells with the combination of biochemical and mechanical strategies, Prof Ouyang’s researches improved structural and functional tendon and cartilage regeneration significantly in vitro and in vivo.He has filed fifteen national patents applications (eight approved) and published more than sixty original research papers in the international journals. These papers corresponded by Prof Ouyang were published in the leading journals of particular fields, such as Stem Cells, Biomaterials, Cell Transplantation(Average IF=6). In 2008, authorized by State Food and Drug Administration, he was involved in drafting the Guide for in vivo assessment of implants for cartilage repair and regeneration YY/T 0606.10-2008, Chapter 10 of Tissue Engineering Medical Products, Pharmaceutical Industry Standard of People’s Republic of China. In 2009, he was again involved in formulating the Provisions for Therapeutic Transplantation of Engineered Tissues announced by the Ministry of Health (MOH). In March of 2010, under the new regulations of the Ministry of Public Health in China, Prof Ouyang established a standard approach for tissue engineered cartilage (TEC) transplantation, and set up the clinical application network of cartilage tissue engineering technology in orthopedics from five third-grade class-A hospitals in Zhejiang.